BBI Contributes to Healthcare Innovation Discussions at the 10th Andalusian Healthcare & Research Meeting
- Feb 12, 2014
- 2 min read
Updated: Jun 1
The Biotechnology Business Institute (BBI) participated in the 10th Annual Andalusian Healthcare & Research Meeting, contributing to discussions on innovation within the Andalusian Public Health System (SSPA). Organised by the Andalusian Public Foundation Progress and Health and promoted by the Andalusian Regional Government's Department of Equality, Health and Social Policies, the event brought together healthcare professionals, researchers, policymakers and industry representatives to explore new approaches to healthcare innovation, technology transfer and cross-sector collaboration.
The 10th edition of the meeting focused on the development of innovation processes within the healthcare environment, including organisational, clinical and technological innovation. Participants examined how many of today's healthcare challenges extend beyond purely medical causes and are increasingly influenced by social and economic factors.
Recognising the need for a multidisciplinary approach, the programme encouraged participation from healthcare professionals, managers, researchers, companies and experts from fields such as engineering, information technology and economics. The objective was to foster an inclusive dialogue on the future of healthcare, innovation and social wellbeing.
The event was designed for healthcare professionals, researchers and managers from healthcare institutions, universities and companies operating within the biomedical and life sciences sectors.
Held on 2 December 2013 at the Andalusian School of Public Health in Granada, Spain, the meeting adopted a more intensive format than previous editions, featuring workshops and collaborative working sessions focused on innovation support mechanisms, current policy initiatives and successful case studies from across the healthcare sector.
The programme concluded with BIOTRANSFER, a dedicated partnering event facilitating bilateral meetings between research groups and healthcare companies. The initiative aimed to encourage knowledge exchange and the development of technology collaboration agreements in key areas including:
Biomedicine and health biotechnology
Medical devices
Digital health and telemedicine
The meeting provided an important platform for strengthening collaboration between academia, healthcare organisations and industry, reinforcing the role of innovation as a driver of improvements in healthcare delivery and patient outcomes.
About the Biotechnology Business Institute
The Biotechnology Business Institute (BBI) is an international business school dedicated to developing scientific managers, entrepreneurs and executives for leadership roles within the life sciences sector. BBI supports business development, executive education and strategic collaboration among key stakeholders across the biotechnology, pharmaceutical and healthcare industries worldwide.
Through its programmes, conferences and industry initiatives, BBI promotes innovation, entrepreneurship and the development of new healthcare solutions addressing unmet medical needs.
For further information about BBI's activities and programmes, please contact us or visit our website. www.bbicambridge.com
Media Contact
Communications Department Biotechnology Business Institute (BBI) info@bbicambridge.com
Disclaimer
This article is published as part of BBI's historical archive of conferences, meetings and industry engagement activities. Information reflects the circumstances and context of the event at the time it took place.
